Search - tctmd.com

Displaying 1 - 9 of 9

Sort: Relevancy | Date

Presentation TCT 2025

TCT 74: Survival Outcomes Following TAVR in Tafamidis-Treated Cardiac Amyloidosis: A Propensity-Matched Analysis

Presenter: Tamari Lomaia

October 26, 2025

Dual Approach the Best Remedy for Aortic Stenosis, Amyloidosis: Registry

News Daily News

Dual Approach the Best Remedy for Aortic Stenosis, Amyloidosis: Registry

June 09, 2025

HELIOS-B: Additional Data Affirm Benefits of Vutrisiran for ATTR-CM

News Conference News ESC Heart Failure 2025

HELIOS-B: Additional Data Affirm Benefits of Vutrisiran for ATTR-CM

May 19, 2025

Vutrisiran, With the FDA’s Sign-off, Joins the Fray for ATTR-CM

News Daily News

Vutrisiran, With the FDA’s Sign-off, Joins the Fray for ATTR-CM

March 21, 2025

TCTMD’s Top 10 Most Popular Stories for February 2025

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for February 2025

February 28, 2025

Even on Tafamidis, ATTR-CM Patients Face High Mortality Over Time

News Daily News

Even on Tafamidis, ATTR-CM Patients Face High Mortality Over Time

Michael O'Riordan

February 13, 2025

Acoramidis Approved in Europe for ATTR Cardiomyopathy

News Daily News

Acoramidis Approved in Europe for ATTR Cardiomyopathy

Michael O'Riordan

February 12, 2025

Tafamidis Impact on Incidence of Pacemaker and ICD Placement in ATTR-CM Patients

Presentation THT 2025

Tafamidis Impact on Incidence of Pacemaker and ICD Placement in ATTR-CM Patients

Presenter: Justin Pawloski

February 12, 2025

Presentation THT Abstracts 2025

Tafamidis Impact on Incidence of Pacemaker and ICD Placement in ATTR-CM Patients

Presenter: Justin Pawloski

February 11, 2025

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.